Download the appMore options
PisaczekSearch
文AEN-US
Diet and nutrition

Weight gain during menopause? It could be insulin and hormones, not overeating!

Sources: 17 · Article: 17 045 characters ↓

What do Natural Therapy Specialists write?

Andrzej Frydrychowski

A slower metabolism may accompany weight gain during menopause, while mood swings can encourage snacking.

„In addition, because mood swings can encourage snacking, depressive states take away the desire to do any activity, especially physical activity. Metabolism slows down and weight gain begins, which is often another companion of menopause. Menopause and weight gain is a broad topic, so we will prepare a separate post about it.”Poza tym, ponieważ wahania nastrojów sprzyjają podjadaniu, stany depresyjne odbierają chęć do jakiejkolwiek aktywności na czele z fizyczną. Przemiana materii zwalnia i zaczyna się tycie, które jest często kolejnym towarzyszem menopauzy. Menopauza a tycie to temat obszerny – dlatego przygotujemy o tym osobny wpis.
Bracia Rodzeń

Carbohydrates raise insulin levels, which signals the body to store energy; Bracia Rodzeń links higher carbohydrate intake with weight gain.

„After eating carbohydrates, insulin levels in the blood rise significantly. Insulin is a hormone that signals the body to store energy. The more carbohydrates you eat, the faster and more weight you will gain, and the more likely you are to develop insulin resistance and other metabolic diseases.”Po spożyciu węglowodanów poziom insuliny we krwi znacznie wzrasta. Insulina to hormon, który daje sygnał do magazynowania. Im więcej węglowodanów w Twoich pokarmach, tym szybciej i bardziej przytyjesz, zachorujesz na insulinooporność i inne choroby metaboliczne.
Henryk Różański

Thyroid hormones stimulate basal metabolic rate.

„Thyroid hormones increase the number and activity of mitochondria in the body's cells. They stimulate basal metabolic rate, increase aerobic respiration, oxidative phosphorylation, and protein synthesis. They stimulate transcription. They increase the absorption of sugars from the intestines and stimulate body growth and the development of the central nervous system.”Hormony tarczycy zwiększają liczbę i aktywność mitochondriów w komórkach ciała. Pobudzają podstawową przemianę materii, zwiększają oddychanie tlenowe, fosforylację oksydacyjną i syntezę białek. Pobudzają transkrypcję. Zwiększają pochłanianie cukrów z jelit, pobudzają wzrost organizmu oraz rozwój ośrodkowego układu nerwowego.
Henryk Różański

Estrogens are linked with the development of cellulite, while progesterone is linked with water retention in connective and fatty tissue.

„Estrogens encourage the development of cellulite, while progestogens (progesterone) encourage the buildup (retention) of water in connective tissue proper and fatty tissue. 4. Long-term depression and stress affect catecholamine levels and encourage the development of cellulitis. 5.”Estrogeny sprzyjają powstawaniu cellulitu, a gestageny (progesteron) sprzyjają kumulacji (zatrzymaniu) wody w tkance łącznej właściwej i tłuszczowej. 4. Długotrwała depresja i stres wpływają na poziom katecholamin i sprzyjają rozwojowi cellulitis. 5.
Thomas E. Levy

Thomas E. Levy attributes fat gain to sugars and carbohydrates, not dietary fats.

„Sugar (carbs) cause fat gain. Fat does not cause fat gain! It is no secret to doctors and scientists familiar with the medical literature that the steady rise in sugar and carbohydrates has fueled the steady rise in atherosclerosis, and this rise is the primary reason for abnormalities in blood fats (cholesterol, lipids) that are known to feed the growth of obstructive coronary artery plaques over time.”Sugar (carbs) cause fat gain. Fat does not cause fat gain! It is no secret to those docs and scientists familiar with the medical literature that the steady rise in sugar and carbohydrates has fueled the steady rise in atherosclerosis, and this rise is the primary reason for the abnormalities in blood fats (cholesterol, lipids) that are known to feed the growth of obstructive coronary artery plaques over time.
Thomas E. Levy

Thomas E. Levy links insulin spikes after eating carbohydrates with increased hunger and overeating.

„Carbs, on the other hand, fuel spikes in blood sugar. These spikes then cause insulin surges, which keep the eater hungry for even more carbs. In other words, carbs promote abnormal glucose metabolism with all its side effects while further stimulating hunger and promoting chronic overeating.”Carbs, on the other hand, fuel spikes in blood sugar. These spikes then cause insulin surges, which keeps the eater hungry for even more carbs. In other words, carbs promote abnormal glucose metabolism with all its side effects while further stimulating hunger and promoting chronic overeating.
Nathan S. Bryan

Nathan S. Bryan links dysfunction in cells of the digestive system with weight gain, and insufficient energy production in cells of the endocrine system with hormone disorders.

„When cells of the gastrointestinal system fail, we get symptoms such as diarrhea, constipation, irritable bowel, immune dysfunction, and weight gain. Our endocrine system is made up of tissues and cells that control the release of hormones. When these cells cannot make sufficient energy, they fail and we develop hormone disorders such as hypothyroidism and imbalances in sex hormones, which lead to symptoms such as chronic fatigue, loss of sexual function, insomnia, exercise intolerance, and hair loss.”When cells of the gastrointestinal system fail we get symptoms of diarrhea, constipation, irritable bowel, immune dysfunction, weight gain. Our endocrine system is made up of tissues and cells that control the release of hormones. When these cells cannot make sufficient energy, they fail and we develop hormone disorders such as hypothyroidism, imbalances in sex hormones which lead to symptoms such as chronic fatigue, loss of sexual function, insomnia, exercise intolerance and hair loss.

What does scientific research from PubMed · Europe PMC say?

We selected 8 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 83 801.

Aim of the study: Polycystic ovary syndrome (PCOS) is a common endocrine disorder that occurs in women of reproductive age. Hyperandrogenism, polycystic ovaries, chronic anovulation, and metabolic abnormalities are common features of PCOS.

Results: These hormones are related to metabolic disorders, such as diabetes and insulin resistance, overweight and obesity, infertility, and disturbed menstrual cycles in patients with PCOS. Pathological changes in these hormones, such as increased insulin, reduced GH, increased ghrelin, and leptin resistance, result in a higher prevalence of diabetes and obesity in women with PCOS. Reduced GH, increased LEAP-2 levels, high basal LH, an increased LH/FSH ratio, high androgen levels, and low estrogen levels are found in PCOS and are linked to infertility. This narrative review aims to clarify changes in hormone profiles, such as insulin, GH, LH, FSH, androgens, estrogen, progesterone, ghrelin, LEAP-2, asprosin, and subfatin, in PCOS, which may reveal new targets for better diagnosis and treatment of PCOS.

Hormonal changes in PCOS. · J Endocrinol 2024
Money for the studygovernment, public institutions
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: This chapter has reviewed the evidence that obesity is characterized by distinct patterns of hormonal changes related both to the degree of obesity and to the distribution of fat tissue. Many of these changes are also seen in people with Cushing's syndrome and polycystic ovary syndrome, particularly hyperinsulinaemia and changes in adrenocortical activity and sex steroid secretion and binding.

Results: Upper-body obesity is characterized by large fat cells with higher LPL activity, elevated basal and stimulated lipolysis, but a low antilipolytic effect of insulin. Results from preliminary investigations of potential candidate genes suggest a possible genetic basis for the hyperinsulinaemia/insulin resistance found in upper-body obesity, but further studies involving larger numbers of people are needed to confirm this. It is hoped that findings from such molecular studies will shed additional light on both the genetic background of obesity and the complex hormonal changes seen at the tissue level. This should help confirm a unifying theory for the causal factors associated with obesity and related conditions.

Hormones and obesity. · Baillieres Clin Endocrinol Metab 1994
Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Obesity is a major global epidemic, with over 300 million people with obesity worldwide and nearly 1 billion adults who are overweight. Being overweight carries significant health risks, reduces quality of life, and impairs socioeconomic success, with profound consequences for health expenditure.

Results: It remains unproven whether their hyperghrelinemia or other gut-hormone abnormalities contribute to the hyperphagia in PWS, in addition to brain defects. Postmortem studies of the human hypothalamus and the development of animal models of PWS can also provide insight into the pathophysiology of abnormal feeding behavior. Changes in orexigenic NPY and AGRP hypothalamic neurons, or anorexigenic oxytocin neurons, have been found in illness and PWS. Functional neuroimaging studies using PET and fMRI will also allow us to tease apart the hormonal and brain pathways responsible for controlling human appetite, and their defects in obesity.

Money for the studygovernment, public institutions
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Several endocrine abnormalities have been reported in obesity. Some of these abnormalities are considered causes of obesity, whereas others are considered secondary effects of obesity and usually return to normal after weight loss.

Results: Also, several endocrine diseases have obesity as one of their clinical manifestations. Hypothyroidism, Cushing's syndrome, GH and testosterone deficiency, polycystic ovary syndrome, insulinoma, hypothalamic lesions, and genetic syndromes often present with obesity. In most of these conditions, appropriate treatment of the underlying disease results in weight loss. In addition, fat cells have been found to be endocrine organs that produce several bioactive peptides involved in regulating fat-cell function.

Obesity and endocrine disease. · Endocrinol Metab Clin North Am 2003
Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Leptin is a hormone secreted by fat cells, the stomach, and the placenta. Age, sex, onset of puberty, and food intake are the most important physiological factors that determine leptin concentration.

Results: Age, sex, onset of puberty, and food intake are the most important physiological factors that determine leptin concentration. Leptin secretion has been shown to be regulated by other hormones such as insulin, glucocorticoids, and sex steroids. Leptin plays an important role in regulating hunger and satiety, as well as in normal sexual maturation. Some studies in people with obesity have shown promising results with leptin administration.

[Leptin]. · Rev Invest Clin 2002
Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Over the past 40 years, the prevalence of obesity has risen dramatically, reaching epidemic proportions. By 2030, the number of people affected by obesity will reach 1.12 billion worldwide.

Results: The gut microbiota plays an important role in various metabolic conditions, including obesity and type 2 diabetes, and influences host metabolism through interactions with enteroendocrine cells that modulate incretin secretion. Gut microbiota metabolites, such as short-chain fatty acids (SCFAs) and indole, directly stimulate the release of incretins from colonic enteroendocrine cells, affecting satiety and food intake. Moreover, bariatric surgery and incretin-based therapies are associated with increased gut bacterial richness and diversity. Understanding the role of incretins, gut microbiota, and their metabolites in regulating metabolic processes is crucial to developing effective strategies for managing obesity and its associated conditions.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Severe obesity is associated with hormonal imbalances, hyperandrogenism, and insulin resistance, all of which adversely affect reproductive physiology. Metabolic and bariatric surgery (MBS) leads to lasting weight loss and metabolic improvement, but its effects on ovarian reserve markers and reproductive hormones in women of reproductive age remain incompletely characterized.

Results: BMI decreased from 42.38 ± 1.41 to 25.65 ± 0.34 kg/m² at 12 months (p < 0.001). AMH declined from 3.13 ± 0.17 to 2.24 ± 0.44 ng/mL; AFC fell from 11.22 ± 1.60 to 7.16 ± 1.63 (right ovary) and from 11.09 ± 1.30 to 6.19 ± 0.86 (left ovary). FSH, LH, and estradiol increased; SHBG nearly doubled (36.26 → 63.77 nmol/L); total testosterone decreased markedly (27.76 → 9.34 ng/dL); FAI fell from 2.73 ± 0.85 to 0.53 ± 0.19; HOMA-IR declined from 3.94 ± 0.46 to 1.66 ± 0.56 (all p < 0.001). Spearman correlations among changes showed inverse associations between ΔSHBG and ΔFAI (ρ = -0.420, p = 0.017), and between ΔHOMA-IR and Δtotal testosterone (ρ = -0.374, p = 0.035). Sleeve gastrectomy was associated with marked improvements in insulin resistance and androgen profiles, accompanied by progressive increases in SHBG and reductions in FAI, AMH, and AFC over 12 months.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Obesity affects 2.5 billion adults, disrupting the hypothalamic-pituitary-ovarian (HPO) axis through adipokine imbalance and aromatase activity. This causes hormonal dysregulation, infertility, and pregnancy risks. Bariatric surgery can restore hormonal balance and improve menstrual regularity. This study evaluates changes in reproductive hormones and cycle regularity over six months after bariatric surgery in Egyptian women with obesity.

Results: Bariatric surgery resulted in a highly significant reduction in body weight and BMI over the six-month follow-up period (p < 0.001). Significant hormonal changes were observed, including increased levels of FSH (p < 0.001) and LH (p = 0.001), a decreased LH/FSH ratio (p = 0.005), and marked reductions in estrogen and progesterone concentrations (p < 0.001). While AMH levels remained stable (p = 0.6), menstrual regularity improved significantly from 20% at baseline to 53.3% after surgery (p = 0.001). Furthermore, the degree of weight loss was significantly and positively correlated with postoperative FSH and LH levels. The interventions were generally well tolerated, with 82.4% of participants reporting no postoperative complications. No significant differences in improvements in weight or hormonal profiles were noted between patients with and without PCOS.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people

“Not stated” does not mean nobody paid — the database does not always record it.

What do orthomolecular medicine doctors write?

Orthomolecular Medicine News Service
„For instance, a study involving men with chronic spinal cord injuries found that vitamin D deficiency was associated with significantly lower total and free testosterone levels, suggesting a potential independent link between the two hormones (100). Impact of Vitamin D Supplementation: The effects of vitamin D supplementation on testosterone levels remain inconclusive. Some randomized controlled trials have shown no significant increase in testosterone levels following vitamin D supplementation in men with normal baseline testosterone (101).”For instance, a study involving men with chronic spinal cord injuries found that vitamin D deficiency was associated with significantly lower total and free testosterone levels, suggesting a potential independent link between the two hormones (100). Impact of Vitamin D Supplementation: The effects of vitamin D supplementation on testosterone levels remain inconclusive. Some randomized controlled trials have shown no significant increase in testosterone levels following vitamin D supplementation in men with normal baseline testosterone (101).
Orthomolecular Medicine News Service
„This explains why: Two patients with identical hormone labs respond very differently. A "perfect" BHRT protocol produces inconsistent outcomes. Chronic stress destroys BHRT progress. Vitamin C deficiency worsens hot flashes, insomnia, and mood swings. Some patients are "low-carb non-responders." GLP-1 agonists work brilliantly for some, but not for others. Metabolic Dysfunction Dominates Modern Health—and BHRT Outcomes. The overwhelming majority of BHRT patients are not metabolically healthy.”This explains why: Two patients with identical hormone labs respond very differently A "perfect" BHRT protocol produces inconsistent outcomes Chronic stress destroys BHRT progress Vitamin C deficiency worsens hot flashes, insomnia, and mood swings Some patients are "low-carb non-responders" GLP-1 agonists work brilliantly in some, not in others Metabolic Dysfunction Dominates Modern Health - and BHRT Outcomes The overwhelming majority of BHRT patients are not metabolically healthy.
Orthomolecular Medicine News Service
„PMID: 11384106 Cryer P (1993) Adrenaline: a physiological metabolic regulatory hormone in humans? International Journal of Obesity and Related Metabolic Disorders 17 Suppl 3:S43-S46. PMID: 8124400 Curhan G, Willett W, Speizer F, Stampfer M (1999) Intake of vitamins B6 and C and the risk of kidney stones in women. Journal of the American Society of Nephrology 10:840-845. PMID: 10203369 Evans R, Currie L, Campbell A (1982) The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. The British Journal of Nutrition 47:473-482.”PMID: 11384106 Cryer P (1993) Adrenaline: a physiological metabolic regulatory hormone in humans? International Journal of Obesity and Related Metabolic Disorders 17 Suppl 3:S43-S46. PMID: 8124400 Curhan G, Willett W, Speizer F, Stampfer M (1999) Intake of vitamins B6 and C and the risk of kidney stones in women. Journal of the American Society of Nephrology 10:840-845. PMID: 10203369 Evans R, Currie L, Campbell A (1982) The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. The British Journal of Nutrition 47:473-482.

Sources (17)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.